Tag: generic drug entry

180-Day Exclusivity: How Patent Law Controls Generic Drug Market Entry

180-Day Exclusivity: How Patent Law Controls Generic Drug Market Entry

The 180-day exclusivity rule under the Hatch-Waxman Act gives the first generic drug company to challenge a patent a temporary monopoly. But delays in launching the drug can block competition for years - hurting patient access and drug prices.